120 related articles for article (PubMed ID: 33721443)
1. Efficacy of low-temperature plasma ablation combined with low-dose cisplatin chemotherapy in laryngeal carcinoma patients and its influence on tumor markers.
Wang P; Wang G
J BUON; 2021; 26(1):132-137. PubMed ID: 33721443
[TBL] [Abstract][Full Text] [Related]
2. Postoperative efficacy of low-temperature plasma radiofrequency ablation in elderly patients with laryngeal carcinoma and its influences on tumor markers and COX-2 and VEGF expressions in laryngeal carcinoma tissues.
Dai X; Wei B; He Y; Zhang Q; Xi J
J BUON; 2020; 25(4):1969-1975. PubMed ID: 33099940
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of bevacizumab combined with nedaplatin in the treatment of ovarian cancer and its effects on tumor markers and immunity of patients.
Zhang H; Chen C; Wang S; Li X; Fan T
J BUON; 2020; 25(1):80-86. PubMed ID: 32277617
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy analysis of Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with Paclitaxel-Cisplatin Chemotherapy in patients with Advanced Ovarian Cancer.
Gao Y; Hao Y; Jia Y
J BUON; 2021; 26(2):553-560. PubMed ID: 34077005
[TBL] [Abstract][Full Text] [Related]
5. Observation of efficacy of TACE combined with HIFU on patients with middle-advanced liver cancer.
Zhang Q; Bian SQ; Lv W; Kou D; Hu HL; Guo SS; Cao ZS
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):239-246. PubMed ID: 31389607
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of cisplatin and low-temperature plasma radiofrequency ablation in advanced laryngeal cancer patients and on the serum survivin levels.
Xing B; Dai B; Wang Q; Li G; Ma J
Am J Transl Res; 2021; 13(6):7394-7399. PubMed ID: 34306511
[TBL] [Abstract][Full Text] [Related]
7. A comparative study on etoposide combined with lobaplatin or cisplatin in the first-line treatment of extensive-stage small cell lung cancer.
Li S; Liang Y; Wu Y; Huang Z; Lin Y; Yang Z; Chen H; Wu A
J BUON; 2020; 25(3):1490-1496. PubMed ID: 32862595
[TBL] [Abstract][Full Text] [Related]
8. Analyses of clinical efficacy of ultrasound-guided radiofrequency ablation in liver cancer adjacent to the gallbladder and its prognosis.
Fan J; He S; Zheng Y
J BUON; 2019; 24(6):2411-2417. PubMed ID: 31983113
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy of bevacizumab combined with gemcitabine and cisplatin combination chemotherapy in the treatment of advanced non-small cell lung cancer.
Duan J; Yang Z; Liu D; Shi Y
J BUON; 2018; 23(5):1402-1406. PubMed ID: 30570865
[TBL] [Abstract][Full Text] [Related]
10. Comparisons of efficacy and safety between docetaxel + cisplatin and paclitaxel + cisplatin and their effects on serum HE4, CA125 and ROMA indicators in patients with ovarian carcinoma.
Han L; Kuang L
J BUON; 2019; 24(4):1544-1548. PubMed ID: 31646806
[TBL] [Abstract][Full Text] [Related]
11. Cetuximab combined with cisplatin improves the prognosis of gastric cancer patients and its effect on P38 MAPK expression.
Chen Q; Shen L; Chen C; He H; Fu Y; Xu L; Wang Y
J BUON; 2019; 24(6):2490-2498. PubMed ID: 31983124
[TBL] [Abstract][Full Text] [Related]
12. Effect of triptolide and chemotherapy on carcinoembryonic and carbohydrate antigens levels and first-line treatment of recurrent nasopharyngeal carcinoma.
Liu C; Yuan X; Liu X; Liang K; Ni Z; Yu G; Zhu L
Cell Mol Biol (Noisy-le-grand); 2021 Aug; 67(2):109-113. PubMed ID: 34817331
[TBL] [Abstract][Full Text] [Related]
13. [Combination chemotherapy with ifosfamide, 5-fuluorouracil, etoposide and cisplatin for advanced urothelial cancer: the treatment results and significance of tumor marker evaluation in response assessment of chemotherapy].
Maezawa T; Yonese J; Tsukamoto T; Ishii N; Fukui I
Nihon Hinyokika Gakkai Zasshi; 2002 Nov; 93(7):727-35. PubMed ID: 12494517
[TBL] [Abstract][Full Text] [Related]
14. [Effects of chemotherapy combined with Chinese herbal medicine Kangliu Zengxiao decoction on tumor markers of patients with advanced non-small-cell lung cancer: a randomized, controlled trial].
Yan GY; Xu ZY; Deng HB; Wan ZY; Zhang L; Zhu JY
Zhong Xi Yi Jie He Xue Bao; 2011 May; 9(5):525-30. PubMed ID: 21565138
[TBL] [Abstract][Full Text] [Related]
15. Research on the efficacy of laryngendoscopic low-temperature plasma ablation on early glottic cancer.
Jing J; Li L; Zheng L; Wu Y; Jiang S; Zhang L; Wang H; Liu G
J BUON; 2020; 25(5):2382-2388. PubMed ID: 33277859
[TBL] [Abstract][Full Text] [Related]
16. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of nedaplatin combined with docetaxel in patients with nasopharyngeal carcinoma and its influence on ECRG4 and VEGF expressions.
Zuo D; Liu G; Deng M; Gao Y
J BUON; 2020; 25(4):1976-1981. PubMed ID: 33099941
[TBL] [Abstract][Full Text] [Related]
18. The effects of carboplatin and etoposide on advanced small cell lung cancer and serum tumor markers in correlation with long-term survival rate.
Ye Q; Lin J; Feng J
Pak J Pharm Sci; 2018 Nov; 31(6(Special)):2779-2782. PubMed ID: 30630783
[TBL] [Abstract][Full Text] [Related]
19. Tumor markers CEA, CA19-9 and CA125 in monitoring of response to systemic chemotherapy in patients with advanced gastric cancer.
Yamao T; Kai S; Kazami A; Koizumi K; Handa T; Takemoto N; Maruyama M
Jpn J Clin Oncol; 1999 Nov; 29(11):550-5. PubMed ID: 10678558
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of highly agglutinative staphylococcin combined with neoadjuvant chemotherapy on patients with intermediate or advanced oral cancer.
Guo N; Lin G; Shi X
Pak J Med Sci; 2022; 38(7):1973-1979. PubMed ID: 36246715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
